Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma
AIDS Malignancy Consortium
AIDS Malignancy Consortium
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
Fox Chase Cancer Center
M.D. Anderson Cancer Center
Roswell Park Cancer Institute